Market capitalization | SEK8.04b |
Enterprise Value | SEK7.30b |
P/E (TTM) P/E ratio | 61.05 |
EV/Sales (TTM) EV/Sales | 8.26 |
P/S ratio (TTM) P/S ratio | 9.09 |
P/B ratio (TTM) P/B ratio | 1.66 |
Revenue growth (TTM) Revenue growth | 0.14% |
Revenue (TTM) Revenue | SEK884.09m |
EBIT (operating result TTM) EBIT | SEK149.40m |
As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.
5 Analysts have issued a Surgical Science Sweden AB forecast:
5 Analysts have issued a Surgical Science Sweden AB forecast:
Dec '24 |
+/-
%
|
||
Revenue | 884 884 |
0%
0%
|
|
Gross Profit | 539 539 |
4%
4%
|
|
EBITDA | 210 210 |
15%
15%
|
EBIT (Operating Income) EBIT | 149 149 |
22%
22%
|
Net Profit | 132 132 |
44%
44%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, offers a procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.
Head office | Sweden |
CEO | Tom Englund |
Employees | 274 |
Founded | 1997 |
Website | www.surgical-science.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.